As of Jan 18
| -0.30 / -1.52%|
The 1 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 105.00, with a high estimate of 105.00 and a low estimate of 105.00. The median estimate represents a +438.46% increase from the last price of 19.50.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.